Skip to main content

Diabetes

  • Bydureon takes on diabetes

    The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately. At the end of January, the Food and Drug Administration approved Bydureon (exenatide), a once-weekly version of the drug Byetta, which was originally developed by Alkermes and subsequently developed further under an alliance between Amylin Pharmaceuticals and Eli Lilly that the two companies formed in 2002. In November 2011, however, Amylin and Lilly terminated their alliance in the wake of an announced diabetes drug partnership between Lilly and Boehringer Ingelheim.

  • FDA clears Abbott's FreeStyle InsuLinx blood-glucose monitoring system

    ALAMEDA, Calif. — A blood-glucose monitoring system created by Abbott has received clearance from the Food and Drug Administration.

  • FDA mulls over making some prescription drugs available over the counter

    SILVER SPRING, Md. — The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

  • Diabetes drug from Lilly, BI hits shelves

    INDIANAPOLIS — A new drug for Type 2 diabetes made by Eli Lilly and Boehringer Ingelheim is available in pharmacies, the companies said Wednesday.

    The two companies announced the availability of Jentadueto (linagliptin and metformin hydrochloride). The Food and Drug Administration approved the drug on Jan. 30.

  • EyeScience Labs launches eye health vitamin targeting diabetics

    COLUMBUS, Ohio — EyeScience Labs on Wednesday introduced a new eye vitamin for people with diabetes.

  • Study: Canadians turning to local pharmacies for more health care

    TORONTO — Patients in Canada increasingly are tapping into the healthcare knowledge, expertise and services available at their local pharmacy, with many of them talking to their pharmacist about one or more healthcare issues other than filling a prescription, according to the findings of a new Nielsen survey commissioned by the Canadian Association of Chain Drug Stores.

  • NCPA brings back diabetes management, long-term care workshops

    ALEXANDRIA, Va. — The National Community Pharmacists Association has renewed two of its pharmacy niche programs.

  • Walgreens: Face-to-face consults with pharmacists, retail clinicians reduce health spend

    LAS VEGAS — Walgreens last week outlined how the company's research has demonstrated the ability of face-to-face pharmacy and Take Care Clinic programs to drive better health outcomes at the IMS Managed Markets Services/Data Niche Conference held here.

    Some of the savings advantages inherent in the offerings provided by Walgreens include:

X
This ad will auto-close in 10 seconds